ASTRAZENECA US COVID-19 VACCINE TRIAL LIKELY TO RESUME THIS WEEK

Highlights

• Late-stage US trial of AstraZeneca's COVID-19 vaccine were put on hold since September 6 after a participant in the company’s UK trial fell ill with a suspiciously rare spinal inflammatory disorder known as transverse myelitis

• Sources claim that they have been told the trial could resume at the end of this week though it was unclear how the illness was characterized by the FDA

&b....